Oroxcell

Oroxcell invests in the development of new technologies within collaborative projects involving both private companies and public research institutions. In most cases, these projects are supported by competitive poles, such as Medicen, and funded by governmental institutions.

 New alternative in-vitro assays as substitutes of animal testing.

 Extension of toxicity tests for evaluating chemicals as recommended by the REACH program.

 Investigation of more predictive models for the assessment of the efficacy of drugs.

 Innovative formulations for administration of medical treatments to children